ArticleHepatitis monthly2013

Metronomic capecitabine in patients with hepatocellular carcinoma unresponsive to or ineligible for sorafenib treatment: report of two cases.

Sara Marinelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.